ZymoGenetics

Home | Contact Us | Sitemap

  • Stock Quote
  • ZGEN:NASDAQ GM
  • Last: $5.92
  • Volume: 175,209
  • As of Nov 20, 2009 ET
  • Minimum 20 minutes delayed

ZymoGenetics Newsflash

Final Phase 1b PEG-IFN lambda AASLD Results

Click to view PDF »

THERAPEUTIC AREAS
  • Hepatitis C
    • PEG-Interferon lambda
  • Immunology
    • IL-21 mAb
    • IL-31 mAb
    • FcγR1a
  • Oncology
    • IL-21
  • Surgical Bleeding
NEWS
  • Nov 5, 2009 - ZymoGenetics Reports Third Quarter 2009 Financial Results
  • Oct 31, 2009 - Bristol-Myers Squibb and ZymoGenetics Present Final Phase 1b Results for PEG-Interferon Lambda in Hepatitis C
  • Oct 28, 2009 - ZymoGenetics to Webcast Presentation at Oppenheimer Healthcare Conference
  • News Archive »
EVENTS
  • Live Webcast
    Q3 2009 ZymoGenetics Inc. Earnings Conference Call
    November 05, 2009 at 4:30 p.m. ET
  • Replay
    Oppenheimer 20th Annual Healthcare Conference in New York City on Wednesday, November 04, 2009 at 10:50 a.m. ET
  • Replay
    UBS Global Life Sciences Conference in New York City on Wednesday September 23, 2009 at 9:30 a.m. Eastern Time
  • Replay
    Thomas Weisel Partners Healthcare Conference in Boston
    Thursday, September 10, 2009 at 3:15 p.m. Eastern Time
  • Events Archive »
CORPORATE RESOURCES
  • 2008 Annual Report
  • Full Year 2008
  • 3rd Quarter 2009


© ZymoGenetics Inc., Terms & Conditions